Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | MMP1 | P03956 | 1/20 | 0.32 |
| ▸ | MMP2 | P08253 | 1/20 | 0.32 |
| ▸ | MMP9 | P14780 | 1/20 | 0.32 |
| ▸ | MMP8 | P22894 | 1/20 | 0.32 |
| ▸ | MMP13 | P45452 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27639115 | 1.00 | LMNA (0.38) | LMNACA1CA2MMP1MMP2 | |
| SCHEMBL5145567 | 1.00 | LMNA (0.38) | LMNACA1CA2MMP1MMP2 | |
| SCHEMBL5146900 | 1.00 | LMNA (0.38) | LMNACA1CA2MMP1MMP2 | |
| SCHEMBL7050453 | 1.00 | LMNA (0.38) | LMNACA1CA2MMP1MMP2 | |
| SCHEMBL17092891 | 1.00 | LMNA (0.38) | LMNACA1CA2MMP1MMP2 | |
| SCHEMBL5145678 | 1.00 | LMNA (0.38) | LMNACA1CA2MMP1MMP2 | |
| SCHEMBL5511527 | 0.90 | — | — | |
| SCHEMBL5513080 | 0.90 | — | — | |
| SCHEMBL5507003 | 0.87 | — | — | |
| SCHEMBL5146895 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070020183-A1 | Perfluoroalkyl-containing complexes, process for their production as well as their use | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2007-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070020183-A1 | Perfluoroalkyl-containing complexes, process for their production as well as their use | AFF1, FRG1, AFF2 | LMNA 2326/4885CA1 3035/4885CA2 3325/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.